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1 INTRODUCTION 
 
1.1 Human placenta and membranes 
The placenta, an organ characteristic for mammals, mediates the contact between 
mother and fetus, providing endocrine secretion and selective exchange of soluble 
substances through an apposition of uterine and trophoblastic vascularized parts. At 
the end of the pregnancy the oval shaped placenta is about 15-25 cm in diameter 
and 2-3 cm thick. It weighs about 500-600 g. During labour, the placenta separates 
from the uterus wall and will be expulsed around 30 min following birth of the baby. 
 
1.1.1 Function of the placenta 
Hormone production 
The placenta has an important endocrine function. Hormones are synthetised mostly 
in the syncytium. The implantation acts as a trigger for hormone production. The 
placenta synthesises as well not only pregnancy-associated proteins, but also protein 
hormones and steroid hormones. In these cases, the trophoblast needs maternal 
and/or fetal precursors to produce them.  
Human chorionic gonadotrophin (hCG) is synthesised by the placental 
syncytiotrophoblast, as opposed to the modulatory Human chorionic gonadotrophin 
releasing hormone (hCGRH) which is synthesized by the cytotrophoblast. Reaching 
the mothers´ blood stream, hCG induces progesterone synthesis in the ovary. 
Eliminated from the mother through the urine, hCG is used as an early pregnancy 
marker. The most important functions of hCG at early pregnancy are the maintance 
of the corpus luteum, the prevention of menstruation and the stimulation of steroid 
production from the placenta. At fetal compartments hCG affects the fetal gonades 
and estimulates the fetal adrenal cortex. Furthermore hCG promotes cellular motility 
and can be considered as an angiogenic factor, inducing neovascularization from 
preexisting blood vessels during the uterine adaptation to early pregnancy (Zygmunt 
et al., 2002; Zygmunt et al., 2003). Another hormone produced by the syncytium is 
human placental lactogen (HPL) which has an anabolic, lipolitic and insulinogenic 
effect, controlling glucose levels. HPL is responsible for the increasing exogen and 
endogen insulin resistance during the pregnancy. 
The most important steroid hormones are estrogens (estradiol, estrone and estriol) 
and progesterone. Estrogens have an anabolic effect and are responsible for the 
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uterine muscle fiber excitement. They are produced in increasing levels by the 
placenta, with a maximum almost at the end of the pregnancy and their precursors 
include dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate 
(DHEAS). Progesteron synthesis is mostly done (over 90%) by maternal cholesterin 
precursors and by a few pregnenolon precursor from maternal adrenal cortex. Fetal 
contribution is therefore very small. At the end of the fourth month of pregnancy, the 
placenta becomes the primary tissue of progesterone synthesis, maintaining the 
ongoing pregnancy. Together with the estrogens, progesterone is responsible for the 
uterine volume and vascularisation increasement as well as breast development 
during the pregnancy. Progesterone in the fetus works as a precursor for the gluco- 
and mineralocorticosteroid synthesis. 
 
Exchange of gases and nutrients 
The major function of the placenta is to mediate an efficient oxygen exchange 
between mother and fetus, without allowing the two circulations to mix. Gas 
exchange in blood operates by simple diffusion. At the end of the pregnancy the fetus 
takes 20-30 ml oxygen per minute from the maternal circulation.  
Glucose and milk acids operate by facilitated diffusion, erythrocytes and lymphocytes 
by diapedesis and water molecules by filtration. The placenta is permeable as well to 
nutrients such as aminoacids, free fatty acids, electrolytes and vitamins which are 
transported in an active way (requiring cell energy) from mother to fetus. Not only 
nutrients, but most drugs and infectious agents also pass easily through the placenta. 
 
Passive immunity 
Different mechanisms are being discussed to explain why the fetus and placenta, 
containing 50% of paternal HLA are not rejected by the mother. Most probably, 
maternal protective antibodies previously sensibilised would prevent the destructive 
effects that an immune response could induce. Moreover, the transport of maternal 
antibodies from the fetus allows the fetus to acquire immunity against diphteria, 
smallpox, measles and other infectious diseases. 
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Warm exchanger 
The fetus is 0.6-1.0°C warmer than the mother. Around 85% of the warm production 
flows through the placenta and the rest through the fetal skin, amniotic fluid, 
membranes and the uterus.  
 
1.1.2 Early placental development 
The fertilized oocyte experiences several mitotic cycles growing up to 32 cells 
(morula) during its way through the Fallopian tube. At nearly day 5 post 
conceptionem (p.c.) it comprises 58 cells and is called a blastocyst (Figure 1.I).  
 
 
 
 
 
 
 
 
 
Figure 1.I – Human blastocyst implantation and early 
placentation. Implantation involves stable adhesion of blastocyst 
to uterine epithelium (A). As the blastocyst transgresses the 
epithelial layer, trophectodermal cells proliferate and invade the 
uterine deciduas (B). The process of embryogenesis results in 
formation of the embryonic sac. Extra-embryonic yolk sac (YS) also 
forms during this time. Further invasion into deciduas results in total 
blastocyst encapsulation (C). The chorion arises trough 
differentiation of trophectodermal cells and will eventually consist of 
cytotrophoblast and syncytiotrophoblast. In humans, fusion of the 
chorion and allantois results in formation of a chorioallantoic 
placenta. ICM: inner cell mass. Figure modified from Moore, 1988 
 
trophectoderm
ICM
uterine epithelium
maternal blood vessel
endometrium
A.
YS
cytotrophoblast
syncytiotrophoblast
maternal blood vessel
decidua
B.
chorion
placenta
allantois
embryonic disc
C.
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At implantation the blastocyst is composed of two cell layers; the blastocyst enters 
the uterus and, during implantation, attaches to the uterine mucosa and penetrates 
the decidua, which is the maternal endometrium modified by the pregnancy.  
Approximately 53 cells build up the outer layer, called trophoblast, (troph, Greek = to 
feed, to nourish; blast, Greek = sprout, shoot) because it supplies the inner layer, 
called embryoblast, with nutrients and oxygen.  
 
Proliferation of the trophoblast 
While the blastocyst penetrates the decidua, trophoblasts proliferate. The outer 
trophoblastic cells, situated right beneath the maternal tissue in utero, merge losing 
their individual cell membrane and forming a syncytium. 
 
Cytotrophoblast and Syncytotrophoblast 
Already at day 8 p.c. the trophoblast is divided into an external part called 
syncytiotrophoblast and an internal part called cytotrophoblast. 
Syncytiotrophoblast develops where trophoblast cells come in contact with maternal 
tissue. The growing syncyciotrophoblast leads to cavities in the maternal decidua, 
which is the beginning of the trabecular stage (day 8 p.c.). Parts of the 
syncytiotrophoblast sprout into the cavities building primary villi (13 to 14 days p.c.). 
Therefore, the chorionic villi are initially composed of a central mass of 
cytotrophoblast surrounded by a thick layer of syncytiotrophoblast.  
At the same time maternal vessels are erroded and maternal blood flows into the 
cavities.  
The primary villi develop to secondary villi by the formation of a mesodermal core. 
Capillaries sprout into these secondary villi generating tertiary villi (Figure 1.II). This 
takes place in the 3rd week p.c..The villi are situated in the intervillous space that is 
filled with maternal blood provided by the uteroplacental arteries. Fetal nutrient 
exchange occurs at the interface between the intervillous space and the chorionic 
villi. Mature human placenta is composed by a fetal and maternal side (Fig. 1.III).  
The part of the placenta facing the mother is composed of 15-20 cotyledons, the 
functional subunits of the placenta. Maternal blood flows from the spiral arteries into 
the cotyledons and is drained back to the maternal blood circulation by the 
endometrial veins.  
Introduction
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The part of the placenta facing the fetus comprises the chorion, the amnion and the 
umbilical cord and is developed from the chorionic plate. The chorionic plate forms 
the ´roof´ of the developing placenta and consists of the amnion and the trophoblast. 
 
 
Figure 1.II – Schematic representation of a mature placenta. A mature 
placenta consists of a fetal and maternal side. The fetal side is built from 
the chorionic plate with the villous, the cytotrophoblast and the intervillous 
space. The cotyledons are separated through the decidual septi from the 
maternal placenta. Every cotyledon is formed by two or more villi and their 
ramifications. Source: (Moore, 1998).  
 
The basal plate is covered by syncytiotrophoblast on the maternal side and consists 
of a basal decidua, which is the portion of the decidua where the implantation site is 
located. The more or less excentrically inserted umbilical cord is covered with 
amnion, a thin avascular layer that continues past the edges of the placenta to line 
the entire hollow sphere of chorion except where it is reflected to cover the umbilical 
cord. 
The amnionic and the chorionic membrane represent the bag that encloses the fetus. 
The membranes normally insert at the edge of the placenta and contain the amnionic 
fluid and the fetus. The amnion covers embryo from the inner side, while the chorion 
does it from the outer side.  
fetal
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umbilical arteriesumbilical vein
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intervillus space
chorion leave
parietal decidua
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endometrial veinsand arteries
maternal circulation
miometrium
basal
decidua
placental
septum
amnion-chorion-membrane
chorionic
plate
Introduction
 
 11
 
 
 
 
 
 
 
 
Figure 1.III – Picture of the placenta, the fetal membranes and the 
umbilical cord 
 
The chorionic membrane is derived from the trophoblast layer and is considered an 
extraembryonic tissue. It is comprised by a mesenchyma and a stratified epithelial 
layer passing over into a trophoblastic layer (cytotrophoblast and 
syncytiotrophoblast). 
 
 
 
 
 
 
 
 
 
Figure 1.IV – Composition of the fetal membranes: amnion 
and chorionic membrane. Bar represents 50 µM 
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The amnion is formed from the epiblast from the inner cell mass at day eight after 
fertilization. As we can see in Figure 1.V the epiblast gives rise to the amnion as well 
as all three embryonic germ layers (ectoderm, endoderm and mesoderm). 
 
 
Figure 1.V – Origin of the embryonic and extraembryonic 
tissues. Diagrammatic Illustration  
 
During the 4th week of gestation, small spaces appear between the inner cell 
embryonic mass and the trophoblast ring. By the 22nd day after the last 
menstruation, these spaces have coalesced to form the amniotic cavity. 
Around the 5th week of gestation, amniotic fluid begins to accumulate within the 
cavity. This fluid increases in quantity and causes the amnion to expand. 
Towards the end of the 12th week the amnion adheres with the mesenchymal inner 
surface of the chorionic plate, a “fusion” of amnion and chorion and the secondary 
yolk sac disapears. 
From a histological point of view, the amniotic membrane is composed of a single 
stratum of slightly flattened epithelial cells, the human amniotic epithelial cells (HAE 
cells), resting on a basement membrane. Under it lays the amniotic mesenchyma 
which is composed of connective tissue synthesized by fibroblast-like cells (see 
Table 1.I).  
EMBRYONIC TISSUES
Blastocyst
Syncitiotrophoblast
Yolk
sac
Inner cell
mass
Trophoblast
Epiblast
Hypoblast
Cytotrophoblast
Extraembryonic
endoderm
Amnionic ectoderm
Embryonic Epiblast
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Table 1.I - Composition of the Fetal Membranes: overview 
 
1.1.3 Role of the early amniotic membrane 
The amnion mediates the exchange of water and possibly nutrients and hormones 
between the maternal blood vessels in the decidua and the amniotic fluid. The intact 
amnion sac provides a buoyant environment that protects the fetus from trauma, and 
allows freedom of fetal movements.  
The functions of the early amniotic membrane and the amniotic epithelium are as 
follows: 
 
Nutrient supply 
The source of nutrients and oxygen may be supplied by diffusion from the deeper 
layers of the uterine wall or via the amnionic fluid from the fetus. 
The presence of glucose transporter proteins 1 and 3 predominantly at the apical 
surface of amniotic epithelial cells has been described, whereas glucose transporter 
protein 4 and insulin receptor could not be detected (Wolf and Desoye, 1993; Desoye 
et al., 1997). Thus it is likely that these cells cover their glucose requirements from 
the amnionic fluid with an insulin-independent mechanism. 
 
Intraamniotic lipid synthesis 
Ultrastructural findings are thought to favour intraamniotic lipid synthesis, rather than 
a degenerative origin of the lipid droplets found in the amniotic membrane. The lipids 
are derived from the maternal circulation and are secreted into the amniotic fluid after 
chemical modifications. Throughout pregnancy the amount of lipid droplets increases 
(Yoshimura et al., 1980). 
 
Glycogen storage as an energy source 
The rich intracellular stores of glycogen present in the amniotic epithelium in early 
pregnancy may provide an energy source that is necessary in view of the poor 
complement of organelles such as mitochondria and endoplasmic reticulum and 
AMNIOTIC 
MEMBRANE 
Bilayer amniotic epithelium + amniotic mesenchyma 
CHORIONIC 
MEMBRANE 
Trilayer Chorionic mesenchyma + chorionic epithelium 
chorionic trophoblast 
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limited pinocytotic activity of HAE cells. It is not known if the amniotic cells manage 
those glycogen stores themselves (Robb and Hytten, 1976).  
 
Role of the amniotic membrane in prostaglandin biosynthesis 
The amniotic membrane is a nearly exclusive source for prostaglandin E2 (PGE2) 
(Okazaki et al. 1981a; Gibb and Sun, 1996; Surendran, 2001; Kumar et al., 2004; 
McCoshen et al., 1989), which play a significant role in the initiation and maintenance 
of uterine contractions. The amnion plays an important role during parturition, 
because of the strategic anatomical location, with its close relation to amniotic fluid, 
myometrium and uterine cervix.  
Enzymes involved in prostaglandin biosynthesis have been found in human amnion 
and include phospholipases, prostaglandin synthase, and prostaglandin 
endoperoxidase synthase (or cyclooxygenase) (Okazaki et al., 1981; Bryant-
Greenwood et al., 1987; Toth et al., 1996a; Smieja et al., 1993; Olson et al., 1991).  
hCG receptors are found on the amniotic epithelium as well suggesting a role for 
hCG in regulating prostaglandin biosynthesis (Reshef et al., 1990; Toth et al., 
1996b). 
Furthermore, corticotropin-releasing hormone (CRH) (Jones and Challis, 1989b) and 
glucocorticoids (Gibb and Lavoie, 1990; Whittle et al., 2000b) modulate prostaglandin 
production (Whittle et al., 2000a). CRH mRNA was demonstrated in amniotic 
membrane of term pregnancies (Okamoto et al., 1990); its production is modulated 
by glucocorticoids and progesterone (Jones and Challis, 1989a; Jones and Challis, 
1990b; Jones and Challis, 1990a). 
Interleukins are well known to regulate prostaglandin biosynthesis and to participate 
in trophoblast invasion into the uterus. Normal amniotic and chorionic cells of the 
membranes produce interleukin- 1ß in vitro, so that intraamnionic infections could 
induce the production of interleukins, which increase prostaglandin production 
(Menon et al., 1995). 
Oxitocine receptors, which act as the myometrial contraction stimulator only when 
combined with increased levels of PGF2α, have been demonstrated in the amnion as 
well as in the chorion (Benedetto et al., 1990). 
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Leukotriene synthesis 
Leukotrienes, a cytokine group derived from arachidonic acid, are produced by the 
amnion (Rees et al., 1988). These cytokines may affect uterine contractility in 
addition to their function as mediators of immune reaction and vasodilatation. 
 
Regulation of the pH of the amniotic fluid 
Amnion epithelium has been shown to exhibit carbonic anhydrase activity which is 
involved in bicarbonate/carbon dioxide exchange (Benirschke, 1998; Bernischke K, 
2000), suggesting that the amnion epithelium may also be partly responsible for 
regulating the pH of amniotic fluid (Gilbert and Brace, 1989). 
 
Steroid transformation 
17ß-hydroxysteroid dehydrogenase activity has also been demonstrated in human 
amnion epithelium from 7 to 20 weeks of pregnancy, suggesting that these cells have 
the ability to transform steroids (Cheung et al., 1992). Comparing early amniotic 
membranes with third trimester membranes, there is an increase in the amniotic 
epithelium complexity: the lateral intercellular connections within the amniotic 
epithelium become more complex, with many interdigitations between the 
desomosomal contacts and the number of microvilli increases as well, allowing more 
water exchange between the mother and the amniotic fluid (Wang et al., 2003). 
 
1.1.4 Characterisation  
The amnion starts to differentiate early in development, at the 8th day after 
fertilization. That is prior to the start of organogenesis, which occurs approximately 3 
weeks after fertilisation. Therefore, amniotic cells have been hypothesised to retain 
pluripotent properties of early epiblast cells. In spite of this interesting “privileged” 
early embryological origin, HAE cells have been poorly characterised. 
The amniotic epithelium arises out of the ectoderm. HAE cells express epithelial 
specific markers such as cytokeratin (Regauer et al., 1985a) and CA125 which is a 
differentiation antigen of fetal coelomic epithelium derived from the mesoderm of 
germ cells (Nanbu et al., 1989a).  
Additionally, non-epithelial but ectodermal markers have been identified as indicators 
for the pluripotent status of HAE cells. This comprises neural markers such as: 
acetylcholine, norephinephrine, dopamine, brain-derived neurotrophic factor (BDNF), 
Introduction
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neurotrophin 3 (NT-3), activin A and noggin (Sakuragawa et al., 1996b; Elwan et al., 
1998a; Elwan et al., 2003f; Elwan and Sakuragawa, 1997b; Kakishita et al., 2000a; 
Koyano et al., 2002c; Okawa et al., 2001; Sakuragawa et al., 1997b; Kakishita et al., 
2003; Sakuragawa et al., 2001; Uchida et al., 2000e; Uchida et al., 2003; 
Sakuragawa et al., 2004d; Elwan et al., 2003d; Elwan et al., 1999e; Ishii et al., 
1999a).  
Furthermore, it has been shown that HAE cells express endoderm specific proteins 
like hepatocyte nuclear factor-3ß, αFP, albumin  and GLUT-2, characteristic for 
hepatic cells (Sakuragawa et al., 2000b; Takahashi et al., 2002; Elwan et al., 2003c; 
Nakajima et al., 2001). The expression of endodermal markers has been of functional 
relevance, because HAE cells can secrete insulin under specific cultivation conditions 
(Wei et al., 2003). 
Finally, vimentin as an intermediary filament of mesenchymal cells arising from 
mesoderm has been also detected in HAE cells (Ko et al., 2004b; Virtanen et al., 
1981; Cremer et al., 1981).   
Like many progenitor stem cells, HAE cells are known to inhibit cellular immune 
function, a property which makes them an attractive candidate for universal donor 
tissues in clinical transplantation. (Akle et al., 1981c; Bailo et al., 2004; Enosawa et 
al., 2003; Heeger, 2004; Kaviani et al., 2002; Mitka, 2001; Miyamoto et al., 2004; 
Terada et al., 2000a). Flow cytometric analyses have revealed that these cells do not 
express any class II antigen on their surfaces. Conversely, Class I antigen is slightly 
expressed (Sakuragawa et al., 1995c; Kubo et al., 2001a; Hunt and Fishback, 1989). 
Various antiangiogenic and antiinflammatory proteins are expressed in HAE cells 
(Hao et al., 2000; Djian et al., 1996; Talmi et al., 1991a) which explains as well the 
antiangiogenic and antinflammatory effects of amniotic membrane transplantation. 
Such properties have already led to the use of amnion tissue as adjuvant therapy for 
a number of disease states, most notably, conjunctiva and cornea surface 
reconstruction (Tseng et al., 1997b; Grueterich et al., 2003a; Solomon et al., 2003b; 
Ueta et al., 2002b; Koizumi et al., 2000; Kubo et al., 2001b; Nakamura et al., 2004b), 
tracheal epithelium reconstruction (Noguchi et al., 1995; Goto et al., 1999) and in 
metabolic diseases (Kosuga et al., 2001; Kosuga et al., 2000; Sakuragawa et al., 
1995b; Takahashi et al., 2001c). This makes HAE cells very interesting also for 
further application because they are easily available during cesarean section. 
 
Aim of the study
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2 AIM OF THE STUDY 
 
Since no standarised protocols for HAE cells are available, the aim of the study was:  
1. to optimize and standarise the isolation and cultivation method for HAE cells 
2. to characterize HAE cells ex vivo 
3. to examine the expansion and pluripotency markers on HAE cells 
 
Material and Methods
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3 MATERIALS AND METHODS 
3.1 Materials 
 
3.1.1 Equipment 
Canon Eos 300 Digital, Canon Germany GmbH, Krefeld 
Centrifuges: Labofuge GL, Heraeus Sepatech, Hanau 
ELISA-Reader, Dynatech MR 5000, Dynatech, Guyanocourt, France 
FACScalibur, Becton Dickinson Labware, Heidelberg 
Incubator for Cell Culture: Heraeus 6000, Heraeus, Hanau  
Laboratory Vacuum pump, Vacusafe, Integra bioscience, Fernwald 
Leica Microscope MS-5, Light source: KL 1500 LCD, Wetzlar 
Leica DM-LB microscope, Wetzlar  
Micropipettes, Eppendorf, Hamburg 
Multipipettes plus, Eppendorf, Hamburg 
Pipettboy acu, Integra bioscience, Fernwald 
PowerPac 200, Bio-Rad Laboratories GmbH, Munich 
Spectophotometer SmartSpec 3000, Bio-Rad Laboratories GmbH, Munich 
Sterile Flow Bank: Gelaire, Flow Laboratories  
Thermal cycler, Mastercycler gradient, Eppendorf, Hamburg 
Vortex, Heidolph Instruments GmbH&Co. KG, Schwabach 
Waterbath, Memmert GmbH&Co. KG, Schwäbach 
WesternBlot, Mini Trans-Blot Electrophoretic Transfer Cells, Bio-Rad Laboratories 
GmbH, Munich 
 
3.1.2 Materials  
Cell Scraper, TPP AG, Trasadingen, Switzerland 
Cell Strainer, Becton Dickinson Labware, Heidelberg 
Cryotubes TM Vials, Nunc TM Brand Products, Roskilde, Denmark 
Electrophoretic Paper, Pharmacia GmbH, Karlsruhe 
FACS tubes, Becton Dickinson Labware, Heidelberg 
Falcon tubes, Greiner, Frickenhausen  
Hemocytometer, Neubauer, Roth, Karlsruhe 
OTC-compound "Tissue-Tek", Sakura Finetek Europe, Zoeterwoude, Holland 
Pasteur pipettes, Brand GmbH, Wertheim 
Material and Methods
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Pipettes (serological), Becton Dickinson Labware, Heidelberg 
Pipettes tips, Sarstedt, Nümbrecht  
SuperFrost Ultra Plus microscope slides, Menzel, Braunschweig 
Scalpel, PFM, Cologne 
Cell culture flasks, Biochrom, Berlin  
 
3.1.3 Chemical products 
Agarose Neeo, Ultra-Qualität, Roth, Karlsruhe 
Ammoniumpersulfate (APS), Sigma-Aldrich, Taufkirchen 
Bisbenzimide Höchst 33342, Merck Biosciences, Darmstadt 
Bromphenolblue, Sigma-Aldrich, Taufkirchen 
Bisacrylamide, Roth, Karlsruhe 
Collagenase, Sigma-Aldrich, Taufkirchen 
Dil-Ac-LDL, Biomedical Technologies Inc, Stoughton, MA, USA 
Dimethylsulfoxide (DMSO), Roth, Karlsruhe  
dNTP Mix, Eurogentec, Seraing, Belgium 
Donkey serum, Jackson ImmunoResearch, West Grove, Pennsylvania, USA 
Dithiotreitol (DTT), Invitrogen, Karlsruhe 
ECL WesternBlotting Analysis System, Amersham Bioscience, Freiburg   
ECL Hyperfilm, Amersham Bioscience, Freiburg   
ECL horseradish peroxidase (HRP) labelled anti-mouse, Amersham Bioscience, 
Freiburg   
Ethylenediamine Tetraacetic Acid (EDTA), Sigma-Aldrich, Taufkirchen  
Endothelial Cell Basal Medium-2 (EBM-2), Cambrex Bioscience, Walkersville, USA 
Endothelial Basal Cell Medium MV2, Promocell, Heidelberg 
Eosin, Merck, Darmstadt 
Ethanol, Fischer, Saarbrücken 
Ethidium Bromide, Sigma Aldrich, Taufkirchen 
Fetal Calf Serum (FCS), Biochrom, Berlin 
Gene Ruler, DNA ladder 100bp, Fermentas GmbH, St. Leon-Rot 
Glycine Hydrochloride, Sigma-Aldrich, Taufkirchen 
Glycerol, Sigma-Aldrich, Taufkirchen 
Hämatoxylin, Waldeck, Münster 
Hank´s balanced salt solution (HBSS-buffer) 10X, Invitrogen, Karlsruhe 
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Loading Dye Solution 6x, Fermentas GmbH, St.Leon-Rot 
Mammary Epithelial Cell Growth Medium plus Supplement Mix, Promocell, 
Heidelberg 
MEM Medium, Invitrogen, Karlsruhe 
Methanol (MetOH), Riedel-de Häen, Seelze 
MiniProtean-3 kit , Bio-Rad Laboratories GmbH, Munich 
NP-40, Sigma-Aldrich, Taufkirchen 
Sodiumhydroxide (NaOH), Merck Biosciences, Darmstadt 
Ammonium Cloride (NH4 Cl), Fluka Chemie, Buchs 
Ammonium Bicarbonat (NH4 HCO3), Fluka Chemie, Buchs 
Paraformaldehide, Sigma-Aldrich, Taufkirchen 
PBS tablets 1x, Invitrogen, Karlsruhe 
Penicilline/Streptomycine, Sigma-Aldrich, Taufkirchen  
Picric Acid solution, Fluka Chemie, Buchs 
Bio-Rad Dc Protein Assay Kit, BioRad Laboratories GmbH, Munich 
Polyvinylidenedifluoride (PVDF) membrane, Amersham Bioscience, Freiburg 
Retinoic Acid, Sigma-Aldrich, Taufkirchen 
RNA extraction kit, RNeasy Mini kit, Qiagen, Hilden 
RNase Reverse Transcriptase, SuperScript II, Invitrogen, Karlsruhe 
Dodecylsulfate sodium salt (SDS), Roth, Karlsruhe 
Slow Fade Light Antifade, Molecular Probes, Eugene, Oregon, USA 
Sucrose, Serva, Heidelberg 
Temed, Roth, Karlsruhe 
Taq DNA Polymerase, Invitrogen, Karlsruhe 
Tris (2-Amino-2-(hydroxymethyl)-1,3-propanediol), Roth, Karlsruhe 
Triton X-100, Sigma-Aldrich, Taufkirchen 
Tryphan Blue, Flow Laboratories, Irrine, Scotland 
Trypsin-EDTA (1X) Invitrogen, Karlsruhe 
Tween 20, Roth, Karlsruhe 
 
3.1.4 Antibodies 
Following antibodies were used in this study:  
AFP-FITC, Santa Cruz, Heidelberg 
CD14 PerCP, Becton Dickinson, Heidelberg 
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CD45 PerCP, Becton Dickinson, Heidelberg 
CD34 FITC, Becton Dickinson, Heidelberg 
CD140b PE, Becton Dickinson, Heidelberg 
CD141 PE, Becton Dickinson, Heidelberg 
CD62e APC, Becton Dickinson, Heidelberg 
CD31 FITC, Becton Dickinson, Heidelberg 
CD83 APC, Becton Dickinson, Heidelberg 
CD144 unlabeled, Becton Dickinson, Heidelberg 
CD133 PE, Milteny Biotech, Bergisch Gladbach 
CD105 unlabeled, Serotec, Düsseldorf 
Cytokeratin 14, 15, 16, 19 FITC, Dako Cytomation, Hamburg 
Goat IgG- APC, Becton Dickinson, Heidelberg 
Mouse IgG1 –FITC, Becton Dickinson, Heidelberg 
Mouse IgG2a –FITC, Becton Dickinson, Heidelberg 
Mouse IgG1 –PE, Becton Dickinson, Heidelberg 
Vimentin-RhodRedX, Santa Cruz, Heidelberg 
Vimentin PE, SantaCruz, Heidelberg 
vWF unlabeled, Becton Dickinson, Heidelberg 
Further details are presented in Chart 2.III 
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3.2 Methods 
 
3.2.1 Isolation and cultivation of human amniotic epithelial (HAE) cells  
Human placentas were obtained from uncomplicated term pregnancies delivered by 
elective Cesarean Sections (CS) from healthy women between the ages of 19 and 
31. Written consent for the use of these tissues was obtained. The study was 
approved by the local Ethics Comitee at the Medical Faculty, University of Giessen, 
Germany. 
There were no evidences of congenital malformation, genetical aberration, severe 
diseases (fetal or maternal) or signs of infection. 3 males and 1 female infant were 
born from 3 different women (one of the placentas was monoamniotic bichorial). 
HAE cells were isolated immediately following the CS using a modified method based 
on previously published approaches (Casey and MacDonald, 1996b; Wei et al., 
2003; Bilic et al., 2004b). All manipulations were carried out under sterile conditions. 
Human amniotic membrane tissue was mechanically peeled free from the chorion 
(Figure 2.I) and was cut with a scalpel about 2 cm from the placental disc to avoid the 
“zone of altered morphology” (McLaren et al., 1999; El Khwad et al., 2004).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.I - Separation of the amniotic membrane (left) from the 
chorionic membrane (right) by blunt dissection. 
 
Amnion was washed several times with ice-cold, calcium-free, phosphate buffered 
saline pH 7.2 (PBS) (Invitrogen, Karlsruhe) to remove blood and cellular debris. 
Blood-free amnion was divided in 3-4 pieces, (1-3 g each). Each piece was then 
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transferred into a Falcon tube (Greiner, Frickenhausen; Germany) containing 20 ml of 
0.05% Trypsin-EDTA (Invitrogen) and was incubated at 37°C for 20 min in a shaking 
waterbath. The digest was poured over gauze through a stainless steel mesh (Becton 
Dickinson Labware, Heidelberg, Germany) in order to separate the dispersed 
amniotic epithelial cells from undigested tissue. Cells were then suspended in 60 ml 
HBSS (Invitrogen) containing 10% heated-inactivated fetal calf serum (FCS, 
Biochrom, Berlin) and pelleted by a 5 min centrifugation at 1200 rpm. Pelleted 
epithelial cells from the 1st trypsination were resuspended in Mammary Epithelial Cell 
Growth Medium (MECGM), containing Supplement Mix (Promocell, Heidelberg) and 
10% of FCS. The suspended cells were kept on ice. 
The remaining tissue was subjected to 2nd and 3rd step of trypsination for additional 
20 min. The dispersed epithelial cells of the 2nd and 3rd trypsination were collected 
and combined with the first cell fraction and poured over a cell strainer. 
Cells were cultured in two 75 cm² tissue culture flasks, in MECGM plus Supplement 
Mix with 10% FCS in humidified atmosphere of 5% CO2 at 37°C.  
In order to allow for a high quality RNA extraction at day 0, 1/3 of the final supernate 
was incubated in Erythrocyte Lysis Buffer for 2 min, centrifuged and shock frozen in 
liquid nitrogen. Freshly isolated cells were analysed with flow cytometry at day 0. 
On the 1st day after isolation, cells were washed two times with PBS and the medium 
was replaced.  
To lift adherent HAE cells, cells were washed twice in ice-cold PBS buffer, treated 
with 20 ml of 0.05% Trypsin-EDTA, incubated for 5 min at 37°C and exposed to the 
same amount of MEM medium with 10% FCS. Afterwards, cells were centrifuged for 
5 min at 1500 rpm and the supernatant was discarded. The cell pellet obtained was 
resuspended in MECGM and transferred to a 75 cm² tissue culture flasks. At a 1:2 
split ratio, cells reached the 5th-passage after 5 weeks. HAE cells were used to 
passage 7. The cultivation methods were optimised by testing different media: 
Epithelial Cell Growth Media as well as Endothelial Basal Medium (EBM-2) were also 
used. The optimised method resulted to be Epithelial Cell Growth Medium, because 
upon visual inspection, the majority of HAE cells cultured in Epithelial Cell Growth 
Media survived passaging as opposed to HAE cells cultured in EBM-2.  
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Chart 2.I - Buffer solutions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HBSS-Buffer Erythrocyte Lysis Buffer
HBSS 4.1 g NH4Cl 
10% FCS 0.4 g NH4HCO3 
2.5 µg/ml Amphotericin B 8.5 mg EDTA 
200 mM L-Glutamine 
Distilled water added to 
total volume of 0.5 l 
  
PBS 
PBS (pH 7.2) 
104 U/ml Penicillin/Streptomycin (10 mg/ml) 
2.5 µg/ml Amphotericin B 
 
Mammary Epithelial Cell Growth Medium 
500 ml Mammary Epithelial Cell Growth Medium 
10 ml Supplement Mix®: BPE (0.4%), 
Epidermal Growth Factor (10 ng/ml), Insulin 
(5 µg/ml), Hydrocortisone (0.5 µg/ml), 
Amphotericin B (50 µg/ml) Gentamicin (50 
µg/ml) 
50 ml FCS 
 
3.2.2 Cell counting 
Determination of cell number was performed with a hemocytometer (Neubauer; Roth, 
Karlsruhe, Depth: 0.1 mm, 0.0025 mm2). Cells were suspended in 50 ml of PBS and 
10 µl of this cell suspension was mixed with 90 µl of Trypan Blue (Flow Laboratories, 
Irrine, Scotland). Finally 10 µl of the mixture was transferred to a capillary chamber. 
Cells were counted in 4 quadrants and the total cell number was determined using 
the following formulation: 
n= x 104 x V x DF 
n - Cell number (mean of the 4 quadrants) 
V - Suspension Volume (50) 
DF - Dilution Factor (10) 
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3.2.3 Freezing and thawing HAE Cells  
Cells were trypsinated and centrifuged as previously described. Supernatant was 
discarded and the pellet was mixed with freezing medium. Cells from a confluent 75 
cm2 culture flask were resuspended in 2 ml cold freezing medium and separated into 
2 cryotubes. The tubes were stored at in isopropanol for 24 h at -80°C before 
transferred into liquid nitrogen long-term storage tanks. 
 
Freezing medium 
60% FCS 
30% Mammary Epithelial Cell Growth Medium Buffer 
10% DMSO 
 
To thaw HAE cells, cells were removed from liquid nitrogen to a 37°C waterbath for 
3-5 min and transferred to a tube containing 9 ml of Mammary Epithelial Cell Growth 
Medium. After a centrifugation at 4°C, the cell pellet was resuspended in Mammary 
Epithelial Cell Growth Medium and cultured in a culture flask.  
 
3.2.4 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
Characterisation of HAE cells began with analysis of RNA expression of pluripotency 
markers using RT-PCR.  
 
RNA Extraction 
Total RNA from HAE cells at passages 0,1 and 5 was extracted using the RNeasy 
Mini Kit (Qiagen, Hilden, Germany) according to manufacturer´s instructions. Cells 
were lysed by adding an appropiate volume of Buffer RLT. To homogenize the 
sample, the lysate was directly pipeted onto a QIA shredder spin column (Qiagen) 
placed in a 2 ml collection tube, which was centrifuged for 2 min at 1300 rpm. One 
volume (usually 350 µl or 600 µl) of 70% ethanol was added to the homogenized 
lysate, carefully mixed, applied to a RNeasy mini column placed in a 2 ml collection 
tube and centrifuged for 15 s at 1300 rpm. The flow-through was discarded, 700 µl 
Buffer RW1 were added to the RNeasy column and centrifuged for 15 s at 1300 rpm. 
Flow-through and tube were discarded again and transferred into a 2 ml collection 
tube. 500 µl Buffer RPE was pipetted onto the RNeasy column and centrifuged for 15 
s at maximum speed. Flow-through was discarded, 500 µl Buffer RPE was added to 
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the column and centrifuged for 2 min at 1300 rpm to dry the RNeasy silica-gel 
membrane. To elute, the column was transferred to a new 1.5 ml collection tube, 30-
50 µl RNase free water was directly pipetted onto the silica-gel membrane and the 
column was centrifuged for 1 min at 1300 rpm. 
RNA concentration was measured using a Spectophotometer (SmartSpec 3000, Bio-
Rad Laboratories GmbH, Munich). 
 
cDNA synthesis 
During the following step, total cellular mRNA will be transcribed into a 
complementary DNA (cDNA).To transcribe mRNA into cDNA, Superscript II Reverse 
Transcriptase (Invitrogen) was used according to manufacturer´s instruction. In detail, 
5 µg total RNA was added to 1 µl of random Primers (Promega, Madison, Wisconsin, 
USA) with distilled water to a volume of 12 µl. The mixture was heated to 70°C and 
chilled 10 min on ice. Afterwards, 4 µl 5x First-Strand Buffer (Invitrogen), 2 µl 0,1 M 
DTT (Invitrogen) and 1 mM dNTP (Eurogentec, Seraing, Belgium) were added and 
incubated at 42°C for 2 min. 1 µl SuperScript II Reverse Transcriptase was added 
and incubated again at 42°C for 50 min. The reaction was completed after 15 min at 
70°C. 
 
PCR Reaction 
During PCR, high temperature separates the DNA molecules into single strands. 
Synthetic sequences of single-stranded DNA (18-25 nucleotides) serve as primers. 2 
different primer sequences are used to bracket the target region; a 2nd primer is 
complementary to a sequence in the opposite DNA strand at the end of the target 
region. To perform a PCR reaction, a small quantity of the target cDNA is added to a 
test tube with a buffered solution containing DNA polymerase (see Figure 2.II), the 
cofactor MgCl2, oligonucleotide primers and the 4 deoxynucleotides. The PCR 
mixture is taken through replication cycles consisting of:  
 
1. One to several minutes at 94-96°C, this mediates denaturation of the cDNA into 
single strands; 
2. 30 sec at 50-65°C, to allow the primer annealing to their complementary 
sequences on either side of the target sequence;  
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3. 30 sec at 72°C, where the polymerase binds and extends a complementary DNA 
strand from each primer.  
As amplification proceeds, DNA sequence doubles after each cycle. Following 30 
cycles, a theoretical amplification factor of 1 billion is attained.  
All components were gently mixed and added to a thermal Cycler (Mastercycler 
gradient, Eppendorf, Hamburg). Following conditions were used (see Chart 2.II B.): 
 
Chart 2.II - PCR-Reaction 
A. Reaction  B. PCR-running conditions 
41.5 µl H2O  1x 4 °C 5 min 
5 µl 10 x Buffer  1x 80 °C Pause 
1 µl cDNA Product  94 °C 45 sec 
1 µl Primer 1 (10 µM)  
Annealing 
temperature 
30 sec 
1 µl Primer 2 (10 µM)  
30x 
72 °C 45 sec 
0.5 µl DNA-Taq-Polymerase  1x 72 °C 10 min 
 
C. Primers 
Sox-1 848 bp fragment, annealing temperature 58°C 
Primer 1 5´- CTC ACT TTC CTC CGC GTT GCT TCC -3´ 
Primer 2 5´-TGC CCT GGT CTT TGT CCT TCA TCC-3´ 
Sox-2 448 bp fragment, annealing temperature 60°C 
Primer 1 5´-CCC CCG GCG GCA ATA GCA-3´ 
Primer 2 5´-TCG GCG CCG GGG AGA TAC AT-3´ 
FGF-4 370 bp fragment, annealing temperture 55°C 
Primer 1 5´-CTA CAA CGC CTA CGA GTC CTA CA-3´ 
Primer 2 5´-GTT GCA CCA GAA AAG TCA GAG TTG-3´ 
Rex-1 306 bp fragment, annealing temperature 56°C 
Primer 1 5´-GCG TAC GCA AAT TAA AGT CCA GA-3´ 
Primer 2 5´-CAG CAT CCT AAA CAG CTC GCA GAA T-3´ 
Oct-4 182 bp fragment, annealing temperature 56°C 
Primer 1 5´ GGG CTC GAG AAG GAT GTG GT-3´ 
Primer 2 3´ GGG CTC CCA TAG CCT GGG-5´ 
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Electrophoresis 
PCR fragments were separated by their length using Agarose gel electrophoresis. 20 
µl of the PCR reaction was mixed in 6x Loading Dye Solution (Fermentas GmbH, 
St.Leon-Rot) and loaded onto a 1% agarose gel (Roth).  
The agarose was dissolved in 1x TAE- Buffer and 6*104% Ethidium Bromide (Sigma 
Aldrich, Taufkirchen) was added. cDNA bands were visualised, photographed and 
evaluated with the Gel-Doc 2000 and Quantity One Software (Bio-Rad Laboratories). 
 
1x TAE Buffer pH 8 
40 mM Tris-Acetate 
1 mM EDTA 
 
3.2.5 Flow Cytometry  
To analyse HAE cell phenotype at the protein level, flow cytometry was performed. 
Antibodies marked with fluorochromes bind specifically to different epitopes. The 
fluorochromes can be excited by lasers and the emitted fluorescence will be detected 
and analysed using FACScalibur (Becton Dickinson). Flow Cytometer has 3 
components: the fluidics, the optics and the electronics. 
The fluidics are based on the hydrodinamic focusing principle, where the sample is 
introduced as a single cell suspension in the FACScalibur and focused for 
interrogation (Figure 2.II). 
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Figure 2.II - Diagram of FACS. Fluorescence marked cells are 
focused for interrogation in the FACS. The sheath fluid accelerates the 
cell suspension and brings them one in a row to the center of the 
measuring capillary (hydrodynamic focusing). When the cell passes the 
laser beam, a fluorochrome will be excited and will be sent as emitted 
light to the photomultiplier. The light signal will be enforced and 
converted to an electronical signal. The computer analyses the signals 
and presents it digitally (histogram). 
 
In general, the optics generate focused light and collect the light signals deviated by 
the cells.There is 2 types of light sources: Forward Scatter and Side Scatter Light 
(Figure 2.III). 
 
 
 
probe flow
lamp beam
electronic systemcomputerhistogram
FL1FL2 SSCFL4FL3
sheath flow
cells
emitted light
FSC
excited light
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Figure 2.III - Diagram showing the light sources and detector in a 
FACS machine. 
Forward Scatter, or Diffracted Light, does not enter the cell. Its detector, which 
converts the light to electrical pulses, is located along the axis of the incident light in 
the forward direction and gives information about the cell surface area.  
Side Scatter, or Refracted Light, enters the cell and is deflected by it. Therefore, the 
detector which is located at 90° to the laser beam gives information about cell 
granularity and complexity.  
Furthermore, the laser can excite fluorochromes, which are coupled to specific 
antibodies binding to cell epitopes. As the sample intercepts the laser beam, the 
electrons of the fluorochromes are excited to a higher energy state. When the 
electrons fall to their starting energy level, energy is released as a photon with 
specific emission spectra unique to different fluorochromes. Therefore a parallel 
analysis of one sample with several antibodies which are conjugated with different 
fluorochromes can be performed. 
The electronic system converts the optical signals to proportional electronic signals 
and digitises them for computer analysis. Data in this work were presented as the so 
called Two Parameter Dot Plots. At the x- and y-axes, the results for every 
fluorescences (FITC: fluorescein isothiocyanat and PE: R-phycoerythrin, respectively 
in the Figure 2.IV) are shown. Every dot represents a counted cell (event).  
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Figure 2.IV - Two parameter Dot Plot displaying CD34 on the x axis  
and CD33 on the y axis. 
 
To perform flow cytometry analyses of HAE cells of passages 0, 1 and 5, the cells 
were used directly after isolation or were subjected to the trypsination protocol to 
obtain a single cell suspension. Depending if the antibodies recognised an extra- or 
intracellular epitope, the cells were subjected to different protocols.  
Extracellular staining 
Detection of extracellular epitopes was performed with antibodies shown in Chart 
2.III. 200.000 HAE cells (per tube/probe) were resuspended in 100 µl of PBS. To 
minimise unspecific binding, cells were blocked with 10 µl human serum for 15 min 
on ice. Primary antibodies were added (see Chart 2.III) and the cells were incubated 
on ice for 45 min. Cells were washed with 1 ml PBS and centrifuged for 5 min at 1200 
rpm. The supernatant was discarded and the pellet vortexed.  
Afterwards, cells marked with directly coupled antibodies were resuspended in 0.5 ml 
PBS and kept in dark. Probes with uncoupled primary antibodies were incubated with 
secondary antibodies coupled with APC (1 µl, Becton Dickinson) and kept on ice in 
the dark for 30 min. Samples were finally washed with 1 ml PBS, centrifuged for 5 
min at 1200 rpm. The pellet was resuspended in 0.5 ml PBS and measured with the 
FACScalibur (Becton Dickinson). 
 
 
 
 
 
 
CD
33
CD34
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Chart 2.III - Antibodies used for Extracellular Stainining 
 
Intracellular staining 
Following epitopes were analysed by an intracellular staining (see Chart 2.IV): 
 
Chart 2.IV - Antibodies used for intracellular staining 
 
500.000 HAE cells per probe were used. Cells were incubated for 20 min on ice with 
Cytofix/Cytoperm (Becton Dickinson) (0.5 ml Cytofix/Cytoperm per 1*106 cells) in 
order to permeabilise cell membranes and fix cell structures. After 5 min 
centrifugations at 1200 rpm, cell pellets were washed two times with Permwash 
Buffer (Becton Dickinson). Cells were then resuspended in Permwash, 10 µl of 
Human Serum was added and the samples incubated 10 min on ice. Primary 
Epitope Source 
Final 
Concentration 
Staining 
Concentration 
Vol/200.000 
HAE cells 
Fluorochrome 
CD14 Mouse 5 µg/ml 0,25µg/ml 5 µl FITC 
CD45 Mouse 25 µg/ml 1,25µg/ml 5 µl PerCP 
CD34 Mouse 55 µg/ml 2,75µg/ml 10 µl FITC 
CD140b Mouse  20 µl/106cells 5 µl PE 
CD141 Mouse  20 µl/106cells 5 µl PE 
CD62e Mouse  20 µl/106cells 5 µl APC 
CD31 Mouse  20 µl/106cells 5 µl FITC 
CD83 Mouse  20 µl/106cells 5 µl APC 
CD144 Mouse 0.1 mg/ml 5µg/ml 5 µl - 
CD133 Mouse 55 µg/ml 2,75µg/ml 10 µl PE 
CD105 Mouse 0.2 mg/0.2ml  3 µl - 
mIgG Goat  1 µg/106cells 1 µl APC 
Epitope Source 
Final 
Concentration 
Staining 
Concentration 
Vol/500.000 
HAE cells 
Fluorochrom
e 
vWF Mouse 0.1 mg/ml 5 µg/ml 5 µl - 
Cytokeratin 
14, 15, 16, 19 
Mouse 50 µg/2ml  5 µl FITC 
Vimentin Mouse 30 µl/106cells  7 µl PE 
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antibodies were added and kept on ice for 45 min. Afterwards, cells were washed 
with 1 ml Permwash, centrifuged, and the remaining pellet was vortexed. Cells 
marked with directly coupled antibodies were resuspended in 0.5 ml Permwash and 
kept in dark. Probes with uncoupled primary antibodies were incubated with APC-
conjugated secondary antibodies (1 µl, Becton Dickinson) and kept on ice in the dark 
for 30 min. Samples were then washed with 1 ml Permwash and centrifuged for 5 
min at 1200 rpm. The pellet was resuspended in 0.5 ml Permwash. Samples were 
subjected to flow cytometric analysis using FACScalibur and Cell Quest Pro software 
program (Becton Dickinson) 
As isotype controls, the following antibodies for both intracellular and extracellular 
staining were used (Chart 2.V):  
 
Chart 2.V – Antibodies used for isotype control 
 
3.2.6 Immunohistochemistry and Immunocytochemistry 
Protein expression of HAE cells was additionally analysed with 
immunohistochemistry. Amniotic and chorionic tissues were fixed for 30 minutes in 
Zamboni solution (Jahr and Bretzel, 2003), washed 4 times with PBS first at room 
temperature and then overnight at 4°C, and finally incubated for 24 h in sucrose 
solution (0.18 g/ml PBS). Fixed tissues were embedded in OTC-compound ("Tissue-
Tek", Sakura Finetek Europe, Zoeterwoude, Netherlands) and frozen in liquid 
nitrogen. Afterwards, fixed tissues were cut into 8 µm slices and put on SuperFrost 
Ultra Plus microscope slides (Menzel, Braunschweig). A single cell suspension of 
HAE cells was fixed for 10 min in Zamboni solution, washed overnight with PBS, and 
resuspended in PBS containing 5% native FCS. Small drops (about 5 µl each) of the 
cell suspension were placed on SuperFrost Ultra Plus microscope slides, dried at  
37°C for 20 min, and were then stored at 4°C up to 2 weeks, or at -80°C for longer. 
Tissues or cells were blocked for 10 min with 10% donkey serum (Jackson 
ImmunoResearch, West Grove, Pennsylvania). Primary antibodies, diluted in 1% 
Epitope Source 
Final 
Concentration 
Vol/500.000 
HAE cells 
Fluorochrome 
mIgG1 mIgG1 20 µl/106cells 5 µl FITC 
mIgG2a mIgG2a 20 µl/106cells 5 µl FITC 
mIgG1 mIg1κ 20 µl/106cells 5 µl PE 
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donkey serum/0.1% Triton X-100 (Sigma-Aldrich, Taufkirchen) were incubated on the 
tissue slices or cells overnight at 4°C. 
The following primary antibodies were used:  
 
Chart 2.VI – Antibodies used for immunohistochemistry 
Epitope Source 
Secondary 
Antibody 
Fluorochrome Final Concentration 
Cytokeratin 19 Mouse Donkey FITC 1:100 
Vimentin Goat Donkey RhodRedX 1:200 
AFP Goat Donkey FITC 1:100 
 
Binding of primary antibodies was then visualized following incubation (1 h, room 
temperature) with a mixture of donkey anti-mouse-FITC and donkey anti-goat 
RhodRedX (both from Jackson ImmunoResearch) diluted 1:400 in PBS containing 
5% human serum. Concerning AFP staining, incubation was performed overnight 
with a mixture of polyclonal goat anti-AFP antibody (Santa Cruz) diluted 1:100 in PBS 
containing 1% donkey serum and 0.1% Triton X-100. Nuclei were counterstained 
(blue fluorescence) with bisbenzimide (Höchst 33342, Merck Biosciences, Bad 
Soden; final concentration 5 µg/ml) for 5 min at room temperature. After a final 
washing step with PBS 3 times, slides were embedded into Slow Fade Light Antifade 
(Molecular Probes, Eugene, Oregon). Unspecific binding of primary antibodies was 
estimated using isotype controls. Fluorescence was observed with a Leica DM-LB 
microscope (Wetzlar, Germany) equipped with a Leica DC-200 camera and Leica IM 
1000 software. 
 
 
 
 
 
 
 
 
Zamboni Solution 
20 g Paraformaldehyde 
150 ml C6H3N307 (Picrin Acid) 
2.5% NaOH 
 
Phosphate Buffered Saline (PBS) pH 7.3 up to a final 
volume of 1 l 
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3.2.7 Protein isolation and Western blot analysis 
In order to investigate the protein expression of the transcription factor Oct-4, 
Western Blot analysis was performed.  
 
Protein Extraction 
HAE cells were grown to ∼80% confluency, and subjected to trypsination as 
previously described. The cell pellet was washed twice in ice cold PBS and 
centrifuged for 5 min at 1500 rpm. 
To obtain cytoplasmic protein extracts, the cell pellet was washed quickly in Buffer A, 
and centrifuged at 1300 rpm for a few seconds. The pellet was resuspended in a 
restricted volume of Buffer A plus NP-40 (~120 µl per 10*106 cells), incubated for 10 
min on ice and centrifuged at 3500 rpm for 5 min at 4°C.  
Supernatants, containing the cytoplasmic protein fraction, were collected and stored 
at -80oC. To obtain the nuclear protein extract, the pellet was resuspended in a 
restricted volume of Buffer C (~120 µl per 10*106 cells) and incubated for 30 min on 
ice. After centrifuging at 1400 rpm for 10 min at 4°C, supernatants containing the 
nuclear protein fraction were stored at -80°C. 
 
Chart 2.VII – Protein extraction 
Buffer A  Buffer C  Proteinase inhibitors 
10 mM Hepes pH 7.9  20 mM Hepes pH 7.9  2 µg/ml Antipain 
1.5 mM MgCl2  1.5 mM MgCl2  2.2 µg/ml Aprotinin 
10 mM KCL  420 mM NaCl  1 mM DTT 
0.1% NP-40  0.2 mM EDTA pH 8.0  2 µg/ml Leupeptin 
   25% Glycerin  1 mM PMSF 
      1 µg/ml Pepstatin A 
 
Determination of protein concentration 
The protein concentration of the cellular protein fractions was quantified utilising the 
BioRad DC Protein Assay Kit (BioRad Laboratories). It is a colometric determination 
method where Cystine, Cysteine, Histidine, Tryptophane and Tyrosine molecules 
react with cuprictartrate that allows the statistical determination of the whole protein 
concentration. Afterwards, the Cu+ protein complex reduces the following folin-
reagents by using 1, 2 or 3 carbon-dioxide atoms, during a 15 min incubation at room 
temperature. Those reduced molecules have a characteristic blue colour, detected at 
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650 nm by an ELISA-Reader (Dynatech MR 5000, Dynatech, Guyanocourt, France). 
In parallel, a standard curve was also measured. The protein probes were related to 
the standard curve and protein concentrations determined. 
 
Protein separation using SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
The protein samples were separated under denaturating conditions utilising the 
Laemmli method. With the use of DTT, the disulfate bridges in the native proteins are 
reduced; SDS maintains the protein denaturation and mediates a negative charge on 
the protein complex. This allows for protein separation depending on molecular 
weight. The proteins (20-50 μg/ well) first passed a 6 % stacking gel at 80 V and 
were separated in a 12% SDS-PAGE. The MiniProtean-3 kit (Bio-Rad Laboratories) 
was used for the protein separation. 
 
Chart 2.VIII – Reagents for SDS-PAGE 
 
 
 
  
SDS-PAGE Buffer 
(5x Laemmli-Buffer pH 8.3) 
25 mM Tris-HCl 
250 mM Glycine 
0.1 % SDS 
Protein Loading Buffer (3x Sample Buffer) 
187.5 Mm Tris-HCl  (pH 6.8) 
6% SDS 
150 mM DTT 
30% Glycerol 
0.3% Bromophenolblue 
 Separating gel (12%) Stacking gel (6%) 
Distilled water 5.25 ml 6.1 ml 
Tris-HCl 3.75 ml (pH 8.8) 2.5 ml (pH 6.8) 
Bisacryl 6.0 ml 1.3 ml 
APS 75 µl 75 µl 
Temed 10 µl 10 µl 
 
 
Western Blot analysis 
The separated proteins were transfered to a polyvinyllidendifluoride (PVDF) 
membrane (Amersham, Bioscience, Freiburg). Before transfer, PVDF membranes 
were activated with Methanol for 15 s, then washed for 2 min with destilled water and 
kept in Transfer Buffer for 5 min. The transfer was carried out in Towbin Buffer with 
the electrophoresis Mini Trans-Blot Electrophoretic Transfer Cells (Bio-Rad 
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Laboratories) according to manufacturer´s instruction. The transfer was performed at 
50 V for 45 min. 
 
Immunoprobing  
The immobilised proteins were analysed by the specific antibodies. While the primary 
antibody bound to Oct-4 protein, the horseradishperoxidase (HRP) (Amersham 
Bioscience, Freiburg) conjugated secondary antibody recognised a fragment of the 
primary antibody. After the addition of ECL (Amersham Bioscience), the substrate-
peroxidase reaction emitted photons which were detected on a Hyperfilm ECL  
 (Amersham Bioscience). In detail, the PVDF membrane was first treated for 2 h at 
room temperature with Blocking Buffer. Following blocking, the membrane was 
incubated with 1:1000 monoclonal Oct-4 (Chemicon, Temecula, California, USA) 
antibody solutions in Blocking Buffer at 4°C overnight.   
The blots were thoroughly washed in Tris Buffered Saline plus Tween 20 (TBST, 
Roth, Karlsruhe) (3 x 5 min) and subsequently incubated for 60 min with HRP labeled 
secondary antibody solution (Amersham Bioscience; 1:2000 dilution in Blocking 
Buffer). The detection of the protein bands was done after 3 x 10 min washing with 
TBST by an ECL WesternBlotting Analysis System (Amersham Bioscience). Finally 
the membranes were exposed to an ECL Hyperfilm  
(Amersham Bioscience) and the film was processed. 
 
Chart 2.IX – Reagents for Immunoprobing 
TBST 
1x Tris Buffered Saline 
0.1% Tween-20 
Blocking Buffer 
150ml 1x TBS 
7.5 g BSA 
0.1% Tween-20 
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4 RESULTS 
 
4.1 HAE cells characterization ex vivo 
 
The fetal membranes comprise both amnion and chorion. To provide an overview of 
the lysed tissue, fetal membranes were stained with Hematoxilyn/Eosin (H/E) (Figure 
3.I A). In parallel, fetal membranes were stained with cytokeratin and vimentin 
unconjugated primary antibodies and fluorochrome-conjugated secondary antibodies, 
to differentiate between epithelial and mesenchymal layers (Figure 3.I B) 
 
A                                                                                   B 
 
 
 
Figure 3.I - HE staining (A) and Immunofluorescence (B) of 
fetal membranes. Immunofluorescence detecting positive 
Vimentin (red) and Cytokeratin (green). Höchst staining is shown 
in blue. Scale bar: 50 µM 
 
The first layer of the fetal membranes to be found under the amniotic cavity is the 
amniotic epithelium (Figure 3.I), where HAE cells were isolated from. It includes a 
single monolayer of flattened, cuboidal cells resting on a basement membrane. 
Underlying the amniotic epithelium basement membrane is a compact stromal layer 
representing the amniotic mesenchym.  
amniotic epithelium
amniotic mesenchyma
remnant of 
chorionic cavity
chorionic
mesenchyma
chorionic
epithelium
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The following spongy intermediate zone resulting from incomplete fusion of amniotic 
and chorionic mesenchyma embryologically represents a remnant of the chorionic 
cavity. This zone has a highly variable thickness.  
The remnant of the chorionic cavity continues into the next connective tissue layer, 
the chorionic mesenchyma. Passing over the chorionic mesenchyma, a stratified 
epithelial layer, the chorionic epithelium, is found. In the HE staining the remnant of 
the chorionic cavity can easily be seen. Due to this remnant cavity, both amniotic and 
chorionic membranes can be easily separated. To verify that only amniotic cells were 
isolated, the amniotic membrane was stained after being dettached from the chorion 
(Figure 3.II). This figure confirms that only the amniotic membrane and not the 
chorion was used for further experiments. 
 
 
 
 
 
 
 
 
 
Figure 3.II – H/E staining of the amniotic membrane after 
dissection from the chorionic membrane. Scale Bar: 50 μM 
 
4.2 Isolation of HAE cells for in vitro culture 
 
In order to investigate which HAE cell isolation method was more adequate, different 
published protocols were analysed and modified. Most of these isolation methods 
involved longer or shorter trypsination steps. As most cells were obtained after the 
first and second trypsination, more than three trypsination did not alter the final 
amount of HAE cells (approximately 12 million cells).  
Freshly isolated and attached HAE cells (Passage 0) were flat, cuboidal to columnar 
cells as described by Bernischka and Kaufmann (2000). During cultivation, HAE cells 
acquired a spindle-shaped morphology.  
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Figure 3.III - Appearance of HAE cells culture at passages 0 
(A), 1 (B) and 5 (C). Scale Bar: 66 μM 
 
Following in situ characterisation of HAE cells, cells were also analysed directly after 
isolation and during cultivation (passage 6) by flow cytometry. The results are 
average values from 3 different experiments. Representative data is shown in Figure 
3.IV. Following epitopes characteristic for different cell types and/or germ layers were 
used: 
Within epithelial markers, cytokeratin 19 was strongly positive at passage 0 and 1 
and decreased to 0% at passage 6. Mesenchymal markers like vimentin remained 
strongly positive at passage 0, 1 and 6. Another mesenchymal marker is CD140b 
(syn. PDGF Receptor ß) which is expressed in stromal cells and some endothelial 
cells. Its expression was negative at passage 0 and 1, but it was upregulated at 
passage 6, with 90% positive CD140b cells. Following some endothelial markers, it is 
known that CD31 (syn. PECAM-1, EndoCam) is a transmembrane glycoprotein 
strongly expressed by all endothelial cells. It is supposed to be an adhesion molecule 
for platelets and belongs to the immunoglobulin superfamily. Regarding our results, 
this marker was negative throughout the passages. Another endothelial marker is 
CD62e (syn. E-Selectin) which is an adhesion molecule expressed in the 
endothelium. Its expression in HAE cells was negative throughout the passages. 
Same results were obtained with vWF. Furthermore, CD144 (syn. VE Cadherin) is a 
marker expressed in cadherins and endothelial cells. 20% positive CD144 cells were 
detected at passage 0. CD144 expression was downregulated at passage 6. Another 
marker expressed in vascular endothelial cells is CD141 (syn. Thrombomodulin). 
CD141 expression in HAE cells remained strongly positive at passage 0, 1 and 6. 
A B C
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CD105 (syn. Endoglin) is a marker not only expressed in endothelial cells but also in 
activated monocytes, macrophages and bone marrow cell subsets. Around 30% 
positive cells were detected in HAE cells at passage 0. At passage 6 CD105 
expression was upregulated, with 80% positive cells. CD83 (syn. HB 15), which is 
expressed in dendritic cells, B cells and Langerhans´ cells was also expressed in 
HAE cells. Approximately 50% positive cells were detected at passage 0. CD83 
expression was downregulated at passage 1 and 6, with 90% negative CD83 cells. 
Following more endothelial markers, CD34 (syn. gp105-120) is expressed in 
hematopoetic stem cells and in the capillary endothelium. Around 40-50% positive 
CD34 cells were detected at passage 0. CD34 expression decreased to 10% at 
passage 6. CD133 (syn. AC133, Prominent One) is a pluripotency marker expressed 
in stem cells (Baal et al., 2004a). Approximately 40% CD133 positive cells were 
detected at passage 0. CD133 expression dropped to 10-20% at passage 6. 
Furthermore, CD45 (syn. LCA, T200, Non lineage) which is expressed in 
hematopoetic cells, was not expressed in HAE cells, neither at passage 0,1 nor 6. 
Finally, CD14 (syn. LPS), expressed in myeloid cells, was not expressed neither at 
passage 0, 1 nor 6. 
In summary, HAE cells upregulated mesenchymal markers throughout cultivation, in 
contrast to the downregulation of the epithelial marker cytokeratin. Furthermore, the 
cells did not show strongly any endothelial marker profile. Interesting to remark is the 
expression of CD141, CD105 and more specifically the expression of CD140b, so 
called PDGF receptor ß, which was positive in all isolations at passage 6 (see Table 
3.I) 
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Figure 3.IV – Representative Flow Cytometry Analysis of HAE 
cells. 
 
Directly after isolation (Passage 0) Cytokeratin+/Vimentin+ population was 96.72%, CD105+ 
population was 37.49%, CD83+/CD14- population was 42.12% and CD141+/CD34+ 
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population was 41.61%. At passage 6 (day 28) these populations were 0.22%, 99.38%, 
4.73% and 0.51% respectively (Figure 3.IV). 
 
Chart 3.I – HAE cell characterization during in vitro culture. 
Overview (+++: 75-100% cells, ++: 25-75% cells; -: 0-25% cells) 
 Passage 0 Passage 6 
Cytokeratin 19 +++ - 
Vimentin +++ +++ 
CD140b - +++ 
CD31 - - 
CD62e - - 
vWF - - 
CD144 + - 
CD141 +++ +++ 
CD105 ++ +++ 
CD83 ++ - 
CD34 ++ + 
CD133 ++ + 
CD45 - - 
CD14 - - 
 
Flow cytometric analysis showed the expression of different markers and different 
germ layers. As previously mentioned, HAE cells are formed from amnioblasts 
separated from the epiblast at about the 8th day after fertilisation. Due to this early 
embryological origin, they are presumably able to retain some pluripotency capacity.  
 
4.2.1 HAE cells express pluripotency markers 
The expression of different germ layer specific proteins may indicate a pluripotent 
status of the HAE cells. Therefore, expression of pluripotency marker mRNA like Oct-
4, Rex-1, Sox-1, Sox-2, FGF-4 and Nanog was investigated by RT-PCR. As a 
positive control CD133 positive cells from the umbilical cord blood as a model for 
endothelial progenitor cells were used (Baal et al., 2004b). 
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                  Figure 3.VI – Representative RT-PCR analysis of HAE cells 
 
In Figure 3.VI, the expression of Oct-4 was detected in both passages 1 and 5 from 2 
different HAE cell cultures derived from separate isolations. The expression of Rex-1 
was shown only in passage 1 from 2 different HAE cell cultures. The expression of  
Sox-2 and Nanog mRNA was weak at passage 1 and negative at passage 5 (data 
not shown). Sox-1 and FGF-4 expression was negative. Oct-4 mRNA has a 
functional relevance because the protein was also expressed in HAE cells (Figure 
3.VII). As no commercial Rex-1 antibody was available, the analysis concentrated on 
Oct-4 protein expression. 
 
 
 
 
 
 
Figure 3.VII – Representative Western Blot analysis of HAE 
cells. Expression of Oct-4 in HAE cells directly after 
isolation. 
 
The detection of Oct-4 Protein in HAE cells confirms that HAE cells have the potential 
to not only to express Oct-4 mRNA but also to synthesize it. This stem cell marker 
shows that directly after isolation HAE cells maintain this pluripotency capacity. As a 
remark, no Western Blot analysis was performed in passage 1 or 5. 
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4.2.2 Chorionic epithelial cells express AFP 
Alpha-Fetoprotein (AFP) is known as an oncodevelopmental 70-kDa protein with a 
growth-regulative and immunosuppressive activity (Dudich et al., 1998). 
AFP is secreted by the embryonic liver and yolk sac during perinatal development. 
After 12 week of gestation, the yolk sac degenerates and the fetal liver becomes the 
main site of AFP synthesis. The protein expression level in the circulation of the fetus 
is very high (1-10 mg/ml), but it decreases abruptly soon after birth. By the end of the 
second month postpartum, only trace amounts of AFP can be detected in the 
circulation, and it is almost completely substituted by human serum albumin (Dudich 
et al., 1998). The important role of AFP as proangiogenic factor during vascular 
morphogenesis at the fetomaternal unit has been demonstrated by our group in a 
previous publication (Liang et al., 2004).  
AFP is expressed by some types of malignant tumors, and appears to play a role in 
the suppression of the mother´s immune response to the developing embryo as well 
as in that of a patient to a developing tumor.  
Fetal membranes were stained with AFP unconjugated primary antibodies and 
fluorochrome-conjugated secondary antibodies (Figure 3.VIII). In the 
immunofluorescence, AFP expression is shown at the chorionic membrane, specially 
in the chorionic epithelium bordering the trophoblast. No AFP expression was shown 
at the amniotic membrane.  
 
Figure 3.VIII – Immunofluorescence of fetal membranes. 
Immunofluorescence detecting positive AFP (green). 
Stratification matches Figure 3-I. Scale bar: 50 µM 
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5 DISCUSSION  
 
The interesting properties described in HAE cells arise out of the following 
considerations. Taking into account that human placental tissues are discarded after 
the delivery of the newborn, HAE cells are fetal epithelial cells that usually exist less 
than 10 months in nature. Like stem cells and some immature cells, HAE cells can 
inhibite cellular immune response making them interesting for allogenic 
transplantation. The uncomplicated obtainment of HAE cells is another appealing 
feature. Placenta is abundantly available as a discarded tissue following normal 
delivery. Large number of cells can be derived from this source, without obvious 
ethical problems, as opposed to embryonic stem cell research, which requires the 
destruction of the blastocyst. All of the previous described issues make HAE cells a 
highly interesting source of pluripotent cells.  
Analysing already published approaches, HAE cells express neural (Sakuragawa et 
al., 1996), hepatic (Sakuragawa et al., 2000a) and pancreatic (Wei et al., 2003) 
markers. HAE cell development before the start of the organogenesis would lead 
these cells to have similar properties like early epiblast cells and thus to differentiate 
and contribute to cells from all three germ layers. 
To test whether HAE cells have putative multipotentiality, several studies investigated 
HAE cell expression of neuron, astrocyte or oligodendrocyte markers (Sakuragawa et 
al., 1996; Sakuragawa et al., 2004a). Furthermore, it has been demonstrated that 
HAE cells can synthethise and release acetylcholine in a time-dependent manner 
(Sakuragawa et al., 2000a; Ishii et al., 1999; Sakuragawa et al., 1996; Sakuragawa 
et al., 2004c). HAE cells can also synthesise and release catecholamines such as 
norepinephrine and dopamine (Elwan and Sakuragawa, 1997c; Elwan et al., 2003a; 
Elwan et al., 2003h; Elwan et al., 2003f; Elwan et al., 1999d; Elwan et al., 1999b; 
Elwan et al., 1998a). Furthermore, extensive analyses with various techniques have 
demonstrated that HAE cells and immortalised HAE cells synthesise and release 
brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and nerve growth 
factor (NGF)  (Uchida et al., 2000e). Finally, the synthesis and release of activin A 
and noggin has  been found in HAE cells (Koyano et al., 2002b).  
Continuing with the hepatic system, interesting markers relating the liver are 
expressed in HAE cells. The fetal part of human placenta is composed only from 
ectodermal and mesenchymal tissue (Moore and Persaud 1998, Benirschke and 
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Kaufmann 2000). In remarkable contrast to this view, definitive endodermal markers 
GATA-4 and hepatocyte nuclear factor-3ß have been detected in amnion-derived 
cells by RT-PCR (Wei et al., 2003), and the expression of the endodermal/hepatic 
markers AFP and albumin was shown both at the mRNA and at the protein level 
(Sakuragawa et al., 2000b; Takahashi et al., 2002; Takahashi et al., 2001).  
Cultured amniotic cells strongly expressed mRNA for GLUT-2, a glucose-sensing 
molecule characteristic for beta cells and hepatocytes (Wei et al., 2003). Finally, the 
evidence of albumin synthesis and excretion by HAE cells by immunostaining and 
enzyme-linked immunoassay has been shown (Sakuragawa et al., 2000a). 
Concerning the pancreatic system, markers of pancreatic differentiation, like insulin 
and glucagon, have been found in HAE cells. More concretely, the Wei group, (Wei 
et al., 2003) demonstrated the normalisation of blood glucose in diabetic mice 
transplanted with HAE cells induced to differentiate to insulin expressing cells after 
culture with 10 mM nicotinamide for up 4 weeks. 
Relating the heart, a recent publication showed cardiomyocyte-related gene 
expression of myosin light chain 2 (MLC-2A, MLC-2V) and the transcription factors 
GATA-4 and Nkx 2.5 in induced HAE cells cultured over 14 days in ascorbic acid 
supplemented media (Miki et al., 2005).  
All aforementioned published approaches shed light into the theory that HAE cells 
can express markers belonging to all three germ layers (endoderm, mesoderm and 
ectoderm), apparently due to their epiblastic origin. 
HAE cells lack the expression of MHC class II, and express very low MHC class I 
antigens (Akle et al., 1981; Sakuragawa et al., 1995; Hunt et al., 1988). They are not 
tumorigenic because there was no evidence of tumorigenicity in humans when 
isolated amniotic cells were transplanted into human volunteers to examine their 
immunogenicity or into patients in attempt to correct lysosomal storage diseases 
(Akle et al., 1981). In fact, antimicrobial properties have been shown as well in 
human amniotic membranes (Talmi et al., 1991) when closely situated to a wound 
surface, adhering to it. Therefore its use in conjunctiva or corneal surface 
reconstruction.(Tseng et al., 1997; Grueterich et al., 2003a; Solomon et al., 2003; 
Ueta et al., 2002a; Nakamura et al., 2004b). 
An optimal isolation and cultivation of the cells is needed in order to obtain a 
maximum number of isolated cells in an optimal state. Finally it is not only necessary 
to find an optimised method of isolation and cultivation but also a precise 
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characterisation, in order to demonstrate the HAE cell marker profile. Therefore this 
doctoral thesis can be considered as an attempt to reach this aims. It is important to 
remark that the results shown in this study are derived from HAE cells isolated from 
different human placentas. 
When incubated with collagenase A, cells were collected following centrifugation after 
2 h. Concerning the number of trypsin incubations performed, different strategies are 
described: 
Some authors prefer to discard the supernatant resulting from the first trypsination in 
order to eliminate red blood cells; supernatant obtained from the 2nd (Wei et al., 
2003), 3 rd  and 4 th trypsinations (Casey and MacDonald, 1996b; Bilic et al., 2004b; 
Sakuragawa et al., 1997) is then combined. Other authors combined all supernatants 
from 6  (Terada et al., 2000b) or 3 (Kakishita et al., 2000a; Sakuragawa et al., 1996) 
trypsination steps, including the 1st trypsination. 
According to Moore et al. (2003) protocol, cells were submitted to a single 1.5 h 
incubation and, following centrifugation, the supernatant collected.  
The isolation of HAE cells described in this doctoral thesis was likewise performed 
with trypsin. Regarding HAE cell location on the most external fetal membrane layer, 
amnion epithelium is considered a single monolayer which does not establish strong 
cell-cell adhesion at their lateral sides like other epithelial cells. Consequently trypsin 
is able to to dettach HAE cells from the amniotic basement membrane.  
Collagenase could digest further internal tissues, increasing the risk of mesenchymal 
cell contamination. Therefore, collagenase was not used in this investigation during 
HAE cell isolation. 
Due to the high number of cells obtained after the first trypsination compared to 
further trypsinations, it was decided not to discard any supernatant. Approximately 
70% of HAE cells were obtained after the 1st trypsination, ~ 15% after the 2nd 
trypsination and ~ 10% after the 3rd trypsination, as measured by hemocytometer 
cell counting method after every trypsination. After the 3rd trypsination very few cells 
were obtained. Consequently the here described method optimises previously 
methods by achieving similar amounts of HAE cells using less trypsination steps and 
therefore less time and reagent volume.  
Almost all red blood cells and cellular debris were eliminated from the tissue after 
rinsing the amniotic membrane with PBS. Hence, approximately 5% of the cell 
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population at the end of the isolation consisted of red cells. This population of non-
adherent erythrocytes was discarded after replacing the medium on the 2nd day.  
After dissecting the amnion from the chorion, HE staining was performed in order to 
verify that only amniotic cells were trypsinated. 
Within the amnion, both epithelial and mesenchymal cells are found. HAE cell 
detachment to the basement membrane can be performed by single trypsination, 
whereas longer trypsination periods are needed to obtain amniotic mesenchymal 
cells, because of stronger cell-matrix adhesion. Still, mesenchymal cell contamination 
of the HAE cell culture can unfortunately not be excluded.  
 
5.1 HAE cell characterisation 
 
Prior to this study a precise characterisation of HAE cells was lacking. Some 
publications had shown HAE cells protein expression focusing on the nerve system, 
the hepatic system, the pancreatic system or the cardiac tissue.  
To test whether HAE cells have putative multipotentiality, several studies investigated 
HAE cell expression of neuron, astrocyte or oligodendrocyte markers (Sakuragawa et 
al., 1996; Sakuragawa et al., 2004b). 
Furthermore, it was demonstrated that HAE cells can synthethise and release 
acetylcholine in a time-dependent manner (Sakuragawa et al., 2000a; Ishii et al., 
1999; Sakuragawa et al., 1996; Sakuragawa et al., 2004c). HAE cells can also 
synthesise and release catecholamines such as norepinephrine and dopamine 
(Elwan and Sakuragawa, 1997a; Elwan et al., 2003d; Elwan et al., 2003i; Elwan et 
al., 2003g; Elwan et al., 1999e; Elwan et al., 1999a; Elwan et al., 1998c). 
Furthermore, extensive analyses with various techniques demonstrated that HAE 
cells and immortalised HAE cells synthesise and release brain-derived neurotrophic 
factor (BDNF), neurotrophin-3 (NT-3) and nerve growth factor (NGF)  (Uchida et al., 
2000d). Finally, the synthesis and release of activin A and noggin was demonstrated 
in HAE cells (Koyano et al., 2002a).  
Continuing with the hepatic system, interesting markers relating the liver have been 
found to be expressed in HAE cells. The fetal part of human placenta is composed 
only from ectodermal and mesenchymal tissue (Moore and Persaud 1998, 
Benirschke and Kaufmann 2000). In remarkable contrast to this view, definitive 
endodermal markers GATA-4 and hepatocyte nuclear factor-3ß were detected in 
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amnion-derived cells by RT-PCR (Wei et al., 2003), and the expression of the 
endodermal/hepatic markers AFP and albumin was shown both at the mRNA and at 
the protein level (Sakuragawa et al., 2000b; Takahashi et al., 2002; Takahashi et al., 
2001).  
Cultured amniotic cells strongly expressed mRNA for GLUT-2, a glucose-sensing 
molecule characteristic for beta cells and hepatocytes (Wei et al., 2003). Finally, the 
evidence of albumin synthesis and excretion by HAE cells by immunostaining and 
enzyme-linked immunoassay has been shown (Sakuragawa et al., 2000a). 
Concerning the pancreatic system, markers of pancreatic differentiation, like insulin 
and glucagon, have been found in HAE cells. More concretely, the Wei group, (Wei 
et al., 2003) demonstrated the normalisation of blood glucose in diabetic mice 
transplanted with HAE cells induced to differentiate to insulin expressing cells after 
culture with 10 mM nicotinamide for up 4 weeks. 
Relating the heart, a recent publication showed cardiomyocyte-related gene 
expression of myosin light chain 2 (MLC-2A, MLC-2V) and the transcription factors 
GATA-4 and Nkx 2.5 in induced HAE cells cultured over 14 days in ascorbic acid 
supplemented media (Miki et al., 2005).  
All aforementioned published approaches shed light into the theory that HAE cells 
can express markers belonging to all three germ layers (endoderm, mesoderm and 
ectoderm), apparently due to their epiblastic origin. 
In order to close the existing gap in HAE cell characterisations, the present study 
demonstrated a precise systematic characterisation of HAE cells in vitro. 
It is necessary to remark that the amniotic epithelium is composed of unique amniotic 
epithelial cells exhibiting quite characteristic morphological features. They have a 
relatively small number of intracytoplasmic organelles, microvilli on the apical 
surface, abundant cytoplasmic processes to the lateral and basal sides, and loose 
intercellular connections (Benirschke and Kaufmann, Pathology of the human 
placenta, Springer Verlag, p 268-314)(Matsubara and Sato, 2000). 
This single cell layer appearing as a uniform cell type (King, 1980) is illustrated in 
Figure 3.I. Furthermore, Figure 3.I illustrates that fetal membranes are composed of 
both amnion and chorion, each with an epithelial and mesenchymal component and 
separated by an intermediate zone. 
Cytokeratin is a group of intermediate filaments that is almost exclusively expressed 
in epithelia and represents one of the most important parts of the cytoskeleton. It 
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consists of at least 20 different proteins varying in molecular weight (from 40 to 70 
kD) and showing some epithelium-, organ-, or tumor-specificity (Moll et al., 1982; 
Santini et al., 1996). It is a marker for epithelial cells with an epidermal origin. 
Cytokeratins are relatively stable in vivo, as they remain expressed in most high-
grade carcinomas and traces of it can even be detected in the sarcomatous 
component of a mixed tumor. 
Vimentin is a cytoskeleton protein from mesenchymal cells, this means, fibroblasts, 
condrocytes, osteocytes, endothelial cells and leucocytes. 
Interestingly enough, immunohistochemical data (Figure 3.I B) demonstrates that 
HAE cells in situ express two types of intermediate filaments within the same cell, 
cytokeratin and vimentin. This reforces previously published approaches where HAE 
cells, despite their clearly ectodermal-epidermal origin not only expressed general 
epithelial markers such as cytokeratins (Beham et al., 1988) or epidermal markers 
such as CA 125 (Nanbu et al., 1989b), but also expressed a marker for 
mesenchymally derived cells, vimentin (Wolf et al., 1991; Sakuragawa et al., 1996; 
Uchida et al., 2000c; Regauer et al., 1985b). 
Intermediate filaments play an important role in the differentiation and proliferation of 
cells. During differentiation, transdifferentiation and neoplastic formation, dramatic 
changes occur in the intermediate filament protein expression and organization 
(Bouwens et al., 1997). This expression has been specifically studied in the 
pancreatic system. Vimentin positive cells have been observed in epithelial ducts 
during embryogenesis (Rosenberg, 1995), in the dedifferentiation from adult to 
progenitor ß cells (Zulewski et al., 2001), and during ductal cell proliferation during 
carcinogenesis (Petersen et al., 2003). Conversely, cytokeratin expression alone is 
shown in mature pancreatic epithelial cells. Consequently, vimentin in pancreatic duct 
cells can be considered a useful marker for pancreatic precursor cells (Ko et al., 
2004). Taking into account that vimentin is expressed in cultured HAE cells, their 
ability to differentiate into pancreatic precursor cells could be especulated. This 
hypothesis is enforced by the Wei et al. study, where HAE cells were differentiated to 
secrete insulin.  
Alpha-fetoprotein (AFP) is a protein expressed during development of primitive 
endoderm and reflects therefore endodermal differentiation. It is normally produced 
by the liver and yolk sac of a fetus and it decreases soon after birth. Fetal spina bifida 
or other defects of the fetus' neural tube are associated with elevated levels of AFP. 
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AFP measurement can be performed along with the amniocentesis during 
pregnancy. In contrast to the Sakuragawa group (Sakuragawa et al., 2000b; 
Takahashi et al., 2002; Takahashi et al., 2001), no expression of AFP was shown by 
HAE cells in situ. Positive staining for AFP though, could be demonstrated at the 
epithelial layer of the chorion, specially in the cells bordering the trophoblast. This is 
the same location where most of the double-positive cytokeratin/vimentin chorionic 
cells are found. Because AFP is present in fetal serum, it cannot completely be 
excluded that AFP expression results from a passive absorption/uptake from 
circulating AFP. However, the nuclei of AFP-positive cells does not show any signs of 
apoptosis and the strong and strictly cellular localization of AFP suggests an 
endogenous cellular AFP synthesis.  
Regarding the cultivation media, we tested HAE cell cultivation not only in epidermal 
cell culture media (Epidermal Cell Growth Medium and Accutase)(Accutase PAA, 
Austria) but in media indicated for endothelial cell culture (EBM-2) and for amniotic 
fluid cells (Amniomax and AmnioGrow plus, Invitrogen).The most adequate results in 
terms of number of cells were obtained using Epidermal Cell Growth Medium. 
After culturing HAE cells in Epidermal Cell Growth Media, cells were disposing more 
elongated shape throughout the passages, losing their originally rounder aspect, 
reminding a typical mesenchymal cell morphology (Figure 3.III). Again, as 
mesenchymal cell contamination in HAE cell cultures remains possible, an epithelial 
to mesenchymal transition of HAE cells can be neither confirmed nor excluded.  
HAE cells were characterized using flow cytometry at passage 0, 1 and 6 in order to 
test differences between freshly isolated and cultured cells. Both shorter (1st 
passage) and longer (6th passage) cultured periods were tested. To reduce the 
possibility of mesenchymal cell contamination, trypsinated cells resulting from two 20 
min incubation periods were submitted to flow cytometry. Results illustrate a 
homogenic pattern of cells (Fig. 3.IV), guaranteeing at single cell population of cells 
and excluding the possibility of 2 different cell types. 
After speculating about HAE cell plasticity, the following question arises: can HAE 
cells express differentiation markers? Thus, the expression of epithelial, 
mesenchymal and endothelial markers was investigated.  
Decreased expression of cytokeratin is, in some epithelial cell types like breast 
epithelium, accompanied by the emergence of vimentin (Osborn et al., 1984; 
Seshadri et al., 1996). In vitro studies indicated a link between vimentin and 
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increased motility or invasion in breast (Sommers et al., 1994; Zajchowski et al., 
2001; Gilles et al., 1994b; Ebert et al., 2000), prostate (Ramaekers et al., 1989) and 
cervical (Ebert et al., 2000; Gilles et al., 1994a) cancer lines. Vimentin/Cytokeratin 
co-expression is found in some carcinoma types like renal cell carcinoma, synovial 
sarcoma, endometrium carcinoma or epitheloid sarcoma without evidence of 
dedifferentiation, and even in normal epithelium. This is particularly true for epithelia 
that have evolved from mesenchymal precursors like the urogenital organs 
(Auersperg et al., 2001; Holthofer, 1990), as if these epithelial cells recalled their 
mesenchymal roots. Ovarian surface epithelial cells (Auersperg et al., 1994) and 
normal endometrial glands (Dabbs et al., 1986) mainly in their proliferative phase 
express vimentin.  
HAE cells had showed a cytokeratin-vimentin co-expression pattern immediately after 
isolation (day 0). At passage 6 the expression of cytokeratin decreased and the 
expression of vimentin remained positive.  
A combination of markers were used in conjunction with flow cytometry to explore the 
pluripotency of HAE cells in vitro (Figures 3.I and 3.IV). 
CD105 (syn. endoglin) binds members of the TGF-ß superfamily. It has been found 
that this endothelial cell marker may play a role during early hematopoetic 
development, and so it could be considered as a marker of differentiation (Cho et al., 
2001). The strongly positive expression of CD105 at passage 6 supports our 
hypothesis on HAE cell pluripotency. 
Likewise, CD141 (thrombomodulin) is strongly expressed in HAE cells. CD141 has a 
receptor that binds thrombin and that results in the activation of protein C, which 
degrades clotting factors Va and VIIIa. Mutations in this gene are a cause of 
thromboembolic disease, also known as inherited thrombophilia. It is a useful 
molecular marker for controlling vascular complications in human diabetic 
neuropathy, Behcet´s disease or in hemorrhagic stroke. 
CD140b (platelet-derived growth factor receptor beta) is a member of the platelet-
derived growth factor family that are mitogens from cells of mesenchymal origin. A 
translocation in two chromosomes results in chronic myelomonocytic leukemia. The 
expression of CD140b in HAE cells up to Passage 6 shows a further hint of  HAE cell 
differentiation in mesenchymal cell type (Figure 3. IV). 
Epithelial, mesenchymal and endothelial markers are expressed in HAE cells at day 
0. After HAE cell cultivation in Epidermal Cell Growth Medium, the epithelial marker 
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cytokeratin decreased expression throughout the passages. In contrast, 
mesenchymal markers like Vimentin and CD140b were upregulated. With the 
exception of CD141 and CD105, endothelial markers CD31 and vWF were not 
strongly expressed in HAE cells at day 0.  
After guaranteeing a homogenic population of cells at Passage 0, 1 and 6, it is 
interesting to notice how epithelial origin cells lose their epithelial marker expression 
and acquire a mesenchymal-like marker profile. In spite of HAE cell cultivation in an 
epidermal cell medium, epithelial characteristics of these cells decreases throughout 
the passages. A similar induction of mesenchymal cell markers has been observed 
during the process of epithelial-mesenchymal transition in the pancreas, where 
vimentin filaments follow pre-existing cytokeratin networks (Casaroli-Marano et al., 
1999; Pagan et al., 1996). This epithelial-to-mesenchymal transition has been shown 
to generate proliferative human islet precursor cells (Gershengorn et al., 2004) and is 
related to the insulin expression by differentiated HAE cells (Wei et al., 2003).  
Apparently this evidence could lead us to a false euphory regarding the possibility of 
HAE cells differentiating into insulin secreting cells. 
In the Wei article, a much lower insuline level expressed by the nicotinamide induced 
HAE cells was described, compared to therapeutical levels needed in diabetes 
treatment. Finally, it is not clear if HAE cells demonstrated an authentic epithelial to 
mesenchymal transition or if this induction of mesenchymal cell markers was induced 
by other undescribed factors.  
 
5.2 HAE cell pluripotency 
 
Regarding flow cytometric characterisation, HAE cells demonstrated a potential to 
develop into different cell types. The pluripotency of those cells was confirmed as 
well by the expression of Oct-4 mRNA and protein and Rex-1mRNA at passage 1 in 
HAE cells.  
Oct-4 is a transcription factor unique to totipotent stem cells and is essential for the 
establishment and maintenance of undifferentiated pluripotent stem cells (Pesce and 
Scholer, 2001). When embryonic stem cells are differentiate, Oct-4 is downregulated. 
In vivo mutagenesis has shown that loss of Oct-4 at the blastocyst stage causes the 
cells of the inner cell mass to differentiate into trophectodermal cells (Pesce and 
Scholer, 2001).  
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Rex-1 is expressed in embryonic stem cells and F9 teratocarcinoma cells. Rex-1 
promoter promotes the activity in undifferentiated F9 cells and is involved in the 
decrease of retinoic acid expression (Ben Shushan et al., 1998). When embryonic 
stem cell begin to differentiate into a neuronal cell type, this marker is downregulated. 
The negative expression of Rex-1 mRNA at passage 5 suggest a decrease in 
pluripotency throughout the passages. 
CD 133 is a cell surface glycoprotein localized in membrane protrusions or microvilli 
and is expressed by stem and progenitor cells of hematopoetic and endothelial 
lineages  (Yin et al., 1997; Baal et al., 2004a), neurons and glial cells (Uchida et al., 
2000a), and by some epithelial cells (Corbeil et al., 2000).  
40% HAE cells expressed CD 133 protein at the time of isolation as shown by flow 
cytometry analysis, but not at passage 6, suggesting a possible ability of these cells 
to differentiate into hematopoetic cells.  
The importance of these findings leads as well in the possibility of these genes to be 
expressed at day of isolation, even before cells are placed into culture.  
Recently published study described the stem cell characteristics of HAE cells(Miki et 
al., 2005). The authors focused on the capacity of these cells in vivo to differentiate 
into three germinal layers (endoderm –liver, pancreas-, mesoderm –cardiomyocyte- 
and ectoderm –neural cells).  
Similarly, this article describes a HAE cell isolation based on 3 trypsination steps for 
30 min. The culture medium used was containing EGF (Epidermal Growth Factor), 
which induced a “robust proliferation” of HAE cells, with five cell doublings over 8 
days, in contrast to the lower proliferation rate observed with Mammary Epithelial cell 
Growth Medium. 
Immunohistochemistry results showed not only cytokeratin expression but also Oct-4 
in HAE cells.  
Likewise, freshly isolated HAE cells expressed not only Oct-4 and Rex-1 by RT-PCR 
but also FGF-4, Sox-2 and Nanog, as opposed to the RT-PCR data shown in this 
work, with negative FGF-4, Sox-1, Nanog and Sox-2 mRNA expression.  
More specifically, the expression of nanog and Oct-4 in the Miki et al. article was 
higher in middle layer fraction of the cultures than in the adherent HAE cell fraction, 
suggesting a role of autologous feeder layer serving as a substrate for attachment or 
providing secreted factors which can help induce or maintain undifferentiated HAE 
cells.  
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The article shows no expression of CD34, in contrast to the flow cytometry data 
shown in our work, with 30-40% positive CD34 cells at Passage 0 decreasing to 10% 
at Passage 6.  
HAE cells in the Miki article were submitted as well to flow cytometry, showing the 
presence of the SSEA 3 and 4, TRA1-60 and 1-81 markers, which are not tested in 
this work.  
Furthermore, it demonstrates the expression of pancreas duodenum homeobox 1 
(PDX-1), pair box homeotic gene 6 (Pax-6), NKX2 transcription factor related, locus 2 
(Nkx 2.2), Insulin and Glucagon mRNA after stimulating HAE cells with Nicotinamide, 
atrial and ventricular myosin light chain 2 (MLC-2A, MLC-2V) GATA-4 and Nkx 2.5 
transcription factors after ascorbic acid stimulation and glial fibrilary acidic protein 
(GFAP) and cyclic nucleotide phosphodiesterase (CNP) expression after all-trans 
retinoic acid and FGF-4 stimulation. 
Albumin and alpha-1-antitrypsin (A1AT) expression was shown by real-time 
quantitative PCR when cells were cultured in EGF and dexamethasone.  
In conclusion, the results of this publication confirm some of the data presented in our 
work. Furthermore, other aspects like HAE cell differentiation, which was initally 
shown by Weit et al., were throroughly investigated in the article as well, confirming 
HAE cell capacity to differentiate into multiple cell types. 
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6 SUMMARY 
 
The amniotic membrane is part of the fetal membrane and is composed of the 
amniotic epithelial (HAE) and mesenchymal (HAM) cells that are derived from the 
inner cell mass in the blastocyst. Thus, HAE and HAM cells may be multipotent. It 
has been reported that some differentiation markers for neuronal and hepatic 
parenchymal cells were expressed in HAE cells, suggesting that HAE cells may be a 
good source of stem cells for various cellular therapies. In addition, amniotic cells do 
not express the MHC class II, which may help prevent immune rejection, and can be 
obtained after delivery.  
 
We established a new method for isolation and cultivation of HAE cells and tested the 
pluripotency in different passages. HAE cells were cultured in different enriched 
mediums (with different growth factors) for expansion. 
We have found that HAE cells express Oct-4 mRNA as well as Rex-1 mRNAs 
(pluripotency markers) at passage 0.  
 
Phenotypic characterisation of HAE cells was carried out by a flow cytometer. HAE 
cells from passages 0, 1 and 5 demonstrated the transitive expression of epithelial, 
mesenchymal and endothelial markers. 
In summary, amnion from discarded placenta can be an interesting source of cells for 
regenerative medicine 
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7 ZUSAMMENFASSUNG 
 
Das Amnion ist ein Teil der fetalen Membran, die aus amniotischen Epithelzellen 
(HAE) sowie amniotischen Mesenchymzellen besteht. HAE entwickeln sich aus der 
inneren Zellmasse und zeigen eine vielseitige Expression von neuronalen, 
pankreatischen und hepatischen Differenzierungsmarkern. Anderseits exprimieren 
die Zellen keine MHC-2 Moleküle. Aufgrund dieser Eigenschaften konnten die Zellen 
für verschiedene Zelltherapien angesetzt werden. 
Für die nähere Untersuchung von HAE-Zellen in vivo wurde im Rahmen der 
vorliegenden Arbeit eine neue Aufreinigungsmethode und die 
Kultivierungsbedingungen etabliert. Es konnte gezeigt werden, dass HAE-Zellen 
direkt nach der Aufreinigung wichtige Pluripotenzmarker wie Oct-4 und REX-1 
exprimieren.  
Um das Phänotyp von HAE-Zellen zu charakterisieren, wurden FACS-Analysen mit 
unterschiedlichen Antikörpern durchgeführt. Die Zellen zeigten eine gleichzeitige 
Expression von epithelialen, mesenchymalen und endothelialen Markern. In Laufe 
der Kultivierung der Zellen in vivo stiegt Expression von mesenchymalen Markern 
(Vimentin und CD140b) auf während die Expression von Zytokeratinen und 
endothelialen Markern sich zurück bildete. 
Die Ergebnisse dieser Arbeit zeigen, dass die HAE-Zellen ein Pluripotenzpotenzial 
besitzen und könnten in Zukunft in der regenerativen Medizin verwendet werden. 
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